UK experts call for new HBV (hepatitis B) testing strategy
This article was originally published in Clinica
The UK is facing a growing crisis with regard to the incidence and morbidity of hepatitis B (HBV), and urgently needs to implement a strategy to improve its diagnosis, management and research. So says the Foundation for Liver Research (FLR) in a report addressed to the UK government, citing the Department of Health's own damning statistics.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.